Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients
Argenx SE (NASDAQ:ARGX) showcased long-term data of Vyvgart (IV: efgartigimod alfa-fcab and SC or Hytrulo: efgartigimod alfa and hyaluronidase-qvfc) demonstrating sustained disease control of ...
The Manila Times3h
Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis. Results from the HERCULES phase 3 study showed delay in disability ...
The Manila Times10h
Johnson & Johnson highlights new data, demonstrating long-term sustained disease control in adults living with generalised myasthenia gravis (gMG)
MG-ADL (Myasthenia Gravis - Activities of Daily Living) provides a rapid clinical assessment of the patient's recall of symptoms impacting activities of daily living, with a total score range of 0 to ...
Raymond James Financial Inc. Purchases New Shares in Immunovant, Inc. (NASDAQ:IMVT)
Raymond James Financial Inc. purchased a new position in Immunovant, Inc. (NASDAQ:IMVT – Free Report) in the fourth quarter, ...
Opinion
Lake Gaston Gazette-Observer23hOpinion
The Urgent Need for Better Treatments for Guillain-Barré Syndrome
Five-year-olds can be goofy. That was my first thought several years ago when my son stumbled and fell to the ground. But when he failed to get up and told ...
HighTower Advisors LLC Buys 5,000 Shares of KORU Medical Systems, Inc. (NASDAQ:KRMD)
HighTower Advisors LLC raised its position in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD – Free Report) by 13.0% during the fourth quarter, according to its most recent disclosure with the ...
Is Argenx SE (ARGX) The Most Profitable Biotech Stock To Buy Right Now?
We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...